Research and development incentive receivable, net of current portion
-
59
Total assets
11,399
20,042
Accounts payable
4,279
7,339
Accrued expenses
3,860
6,623
Income tax payable
527
324
Lease liability
38
39
Total current liabilities
8,704
14,325
Total liabilities
8,704
-
Common stock, 0.001 par value 240,000,000 shares authorized 41,439,529 and 38,329,894 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
41
41
Additional paid-in capital
505,510
505,207
Accumulated other comprehensive loss
-104
-82
Accumulated deficit
-502,752
-499,449
Total stockholders' equity
2,695
5,717
Total liabilities and stockholders' equity
11,399
20,042
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.